Kolexia
Duchamp Maude
Pharmacien
Hôpital La Croix-Rousse
Lyon, France
69 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Grippe humaine Infections à coronavirus Pneumopathie infectieuse Maladies virales Pneumopathie virale Maladies transmissibles Infections de l'appareil respiratoire Urgences

Industries

Organon BioSciences
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
DisCoVeRy: Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   24 novembre 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT: pharmacometrics & systems pharmacology   20 septembre 2023
SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results.
Viruses   24 avril 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
The Lancet. Respiratory medicine   21 février 2023
Bari-SolidAct: European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial
Essai Clinique (Oslo University Hospital)   02 février 2023
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin   26 janvier 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Critical care (London, England)   10 janvier 2023
Additional value of chest CT AI-based quantification of lung involvement in predicting death and ICU admission for COVID-19 patients.
Research in diagnostic and interventional imaging   02 décembre 2022
Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS-CoV-2 and monkeypox virus.
Journal of medical virology   21 septembre 2022